Hospital General de México   Report issue

Academic/Hospital Phase 4
Founded: Mexico City Mexico (1567)

Organization Overview

First Clinical Trial
2019
NCT03782155
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital General de México

Active Ingredients

Drugs in Phase 4 Trials (2)

hydroxymethylbutyrate (1 trial)

l-glutamine (1 trial)

Drugs in Other Trials (1)

metformin (glucophage) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3